Metabolic syndrome and urinary cGMP excretion in general population

被引:14
作者
Cui, Renzhe
Iso, Hiroyasu
Pi, Jingbo
Kumagai, Yoshito
Yamagishi, Kazumasa
Tanigawa, Takeshi
Shimamoto, Takashi
机构
[1] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan
[2] Univ Tsukuba, Dept Publ Hlth, Doctoral Program Social & Environm Med, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan
[3] CIIT Ctr Hlth Res, Endocrine Biol Program, Div Biol Sci, Res Triangle Pk, NC 27709 USA
[4] Univ Tsukuba, Dept Environm Med, Doctoral Program Social & Environm Med, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan
[5] Osaka Med Ctr Hlth Sci & Promot, Higashinari Ku, Osaka 5370025, Japan
基金
日本学术振兴会;
关键词
cGMP; nitric oxide; metabolic syndrome; cross-sectional studies;
D O I
10.1016/j.atherosclerosis.2006.02.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To examine the relationship between metabolic syndrome and enclothelial dysfunction, we investigated cross-sectionally the correlation between metabolic risk factors and urinary excretion of cyclic guanosine 3',5'-monophosphate (cGMP), a second messenger of nitric oxide (NO), in 1541 Japanese men and women aged 40-79 years. The 24-h urinary excretion of cGMP was measured using a I-125-labeled cGMP radioimmunoassay and was adjusted for urinary creatinine excretion (nmol/mmol creatinine). The components of metabolic fasting plasma glucose >= 6.11 mmol/l or syndrome were defined based on the following criteria: body mass index (BMI) >= 25.0 kg/m(2), non-fasting plasma glucose level > 11.1 mmol/l, systolic blood pressure >= 130 mm Hg or diastolic blood pressure > 85 mm Hg, high-density lipoprotem (HDL)-cholesterol < 1.03 mmol/l for men and < 1.29 mmol/l for women, and triglyceride >= 1.69 minol/l. The number of components of metabolic syndrome correlated inversely with urinary cGNIP excretion; means of cGMP excretion for the whole group adjusted for age, sex, and cardiovascular risk factors were 53.6, 48.6, 47.9, 44.4 and 42.3 muol/mmol for 0, 1, 2, 3. and 4-5 components of metabolic syndrome, respectively (p=0.002). Our data suggest that a reduction of NO bioactivity concur with clustered features of the metabolic syndrome. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:423 / 428
页数:6
相关论文
共 23 条
[1]   Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease [J].
Boger, RH ;
BodeBoger, SM ;
Thiele, W ;
Junker, W ;
Alexander, K ;
Frolich, JC .
CIRCULATION, 1997, 95 (08) :2068-2074
[2]  
BOGER RH, 1995, ATHEROSCLEROSIS, V117, P273, DOI 10.1016/0021-9150(95)05582-H
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]  
Cook S, 2003, SWISS MED WKLY, V133, P360
[5]   Relationship between urinary cGMP excretion and serum total cholesterol levels in a general population [J].
Cui, RZ ;
Iso, H ;
Pi, JB ;
Kumagai, Y ;
Yamagishi, K ;
Tanigawa, T ;
Shimamoto, T .
ATHEROSCLEROSIS, 2005, 179 (02) :379-386
[6]   Urinary cyclic GMP excretion and blood pressure levels in a general population [J].
Cui, RZ ;
Iso, H ;
Pi, JB ;
Kumagai, Y ;
Yamagishi, K ;
Tanigawa, T ;
Shimojo, N ;
Shimamoto, T .
ATHEROSCLEROSIS, 2004, 172 (01) :161-166
[7]   Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome [J].
Dell'Omo, G ;
Penno, G ;
Pucci, L ;
Mariani, M ;
Del Prato, S ;
Pedrinelli, R .
ATHEROSCLEROSIS, 2004, 172 (02) :383-389
[8]   Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not - The Hoorn study [J].
Henry, RMA ;
Ferreira, I ;
Kostense, PJ ;
Dekker, JM ;
Nijpels, G ;
Heine, RJ ;
Kamp, O ;
Bouter, LM ;
Stehouwer, CDA .
ATHEROSCLEROSIS, 2004, 174 (01) :49-56
[9]   Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689
[10]  
KIRKENDALL WM, 1980, CIRCULATION, V62, pA114